跳至主要内容
临床试验/KCT0000323
KCT0000323招募中未知

Open-label, randomized comparative study to evaluate the pharmacokinetic characteristics of fenofibric acid between Lipidilsupra tablet and HIP0901 capsule in healthy male subjects

Hanmi Pharm0 个研究点目标入组 28 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 45(Year)(—)
性别
Male

入选标准

  • Healthy male volunteers, age between 20 and 45
  • Informed of the investigational nature of this study and voluntarily agree to participate in this study
  • Weight>50kg, BMI of >18kg/m2 and <27kg/m2 subject

排除标准

  • Acute disease within 28 days prior to start of study drug administration
  • Use of any prescription medication within 14 days prior to Day 1
  • Use of any medication within 7 days prior to Day 1
  • Has a severe medical history of hypersensitivity to fibric acid derivative
  • Participation in another clinical study within 30 days prior to start of study drug administration

研究者

发起方
Hanmi Pharm

相似试验